資訊|論壇|病例

搜索

首頁(yè) 醫(yī)學(xué)論壇 專(zhuān)業(yè)文章 醫(yī)學(xué)進(jìn)展 簽約作者 病例中心 快問(wèn)診所 愛(ài)醫(yī)培訓(xùn) 醫(yī)學(xué)考試 在線題庫(kù) 醫(yī)學(xué)會(huì)議

您所在的位置:首頁(yè) > 腫瘤科診療指南 > 2009CCO/PET成像用于小細(xì)胞肺癌診斷

2009CCO/PET成像用于小細(xì)胞肺癌診斷

2014-05-06 16:29 閱讀:1576 來(lái)源:愛(ài)愛(ài)醫(yī) 責(zé)任編輯:張子玲
[導(dǎo)讀] What benefit to clinical management does positron emission tomography (PET) or positronemission tomography/computed tomography (PET/CT) contribute to the diagnosis orstaging of small cell lung cancer (SCLC).

    《2009CCO/PET成像用于小細(xì)胞肺癌診斷》內(nèi)容簡(jiǎn)介:

    What benefit to clinical management does positron emission tomography (PET) or positronemission tomography/computed tomography (PET/CT) contribute to the diagnosis orstaging of small cell lung cancer (SCLC).

    《2009CCO/PET成像用于小細(xì)胞肺癌診斷》內(nèi)容預(yù)覽:

    What benefit to clinical management does PET or PET/CT contribute to the assessment oftreatment response for small cell lung cancer.

    What benefit to clinical management does PET or PET/CT contribute when recurrence ofsmall cell lung cancer is suspected but not proven.

    What benefit to clinical management does PET or PET/CT contribute to restaging at thetime of documented recurrence for small cell lung cancer.

    What is the role of PET when a solitary metastasis is identified at the time of recurrenceand the metastectomy is being contemplated.

    點(diǎn)擊下載***:《2009CCO/PET成像用于小細(xì)胞肺癌診斷》


分享到:
  版權(quán)聲明:

  本站所注明來(lái)源為"愛(ài)愛(ài)醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。

  本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來(lái)源和作者,不希望被轉(zhuǎn)載的媒體或個(gè)人可與我們

  聯(lián)系z(mì)lzs@120.net,我們將立即進(jìn)行刪除處理

意見(jiàn)反饋 關(guān)于我們 隱私保護(hù) 版權(quán)聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2024 Iiyi.Com All Rights Reserved